Panelists:
Dimitris Agrafiotis, PhD
Director of Digital Analytics & AI
Arsenal Capital Partners
Chris Waller, PhD
VP and Chief Scientist
EPAM Systems
Barry Bunin, PhD
Chief Executive Officer
Collaborative Drug Discovery
- Time:
Modern informatics platforms and AI technologies are unlocking new operational and analytics capabilities for drug discovery and development. But there remain outstanding questions about how and where to deploy these tools effectively to get the biggest impact.
In this GEN webinar, three informatics experts—Dimitris Agrafiotis, PhD, Chris Waller, PhD, and Barry Bunin, PhD—discuss how modern informatics platforms and AI technologies can restructure drug research and development workflows in academic labs and pharmaceutical organizations to expedite drug discovery. During the webinar, you will see a demonstration of Collaborative Drug Discovery’s CDD Vault, a scientific data management and electronic laboratory notebook system. The demonstration will feature new AI capabilities in CDD Vault as well as practical applications to drug discovery workflows. Key learning objectives include:
- Key considerations for selecting and deploying informatics platforms in pharmaceutical R&D
- How current trends in pharmaceutical informatics are impacting different organizational scales
- How to evaluate strategies for implementing and integrating modern informatics solutions with legacy systems
- How to assess the role of AI/ML technologies in drug discovery and their practical implementation
A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelists.
Produced with support from:
The post Strategies for Implementing and Optimizing Informatics and AI for Drug Discovery appeared first on GEN – Genetic Engineering and Biotechnology News.
